The postpartum period, especially the first few weeks after childbirth, could be a challenging time for mothers, as they experience adjustments to life with newborns, as well as discomfort and stress brought by postpartum urinary retention, contraction pain, breastfeeding concerns and other puerperal complications. Postpartum care is very significant to promote lifelong physical and psychological well-being of mothers and newborns.

Symptomatic treatment was commonly used for chronic diseases in the past. For example, diabetes was often treated by controlling the increase of glucose and alleviating various diabetes-induced complications with insulin. However, how to prevent diabetes has remained elusive in the scientific and medical community, and it has become a global research hotspot to find out the origin of the disease for early intervention.

On February 21, Zhejiang Provincial Key Laboratory of Precision Diagnosis and Therapy for Major Gynecological Diseases held the 2022 annual academic conference. Academician Ma Ding, Director of the Academic Committee of the Key Laboratory, Academician Wu Tangchun, Deputy Director of the Academic Committee of the Key Laboratory, Professor Kong Beihua of Qilu Hospital of Shandong University, Professor Wang Shixuan of Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Sc

Mutations in genes encoding mitochondrial aminoacyl-tRNA synthetases are linked to diverse diseases. However, the precise mechanisms by which these mutations affect mitochondrial function and disease development are not fully understood.

Immunotherapeutic drugs, as represented by immune-checkpoint blockade (ICB), have achieved tremendous success in curing various tumors in recent years, thus improving the survival and life quality of some tumor patients in an appreciable manner. Recent data from clinical trials on breast cancer patients suggest that ICB, in combination with neo-adjuvant chemotherapy, can improve the pathological complete response (pCR) rate and the event-free survival rate in breast cancer. Neo-adjuvant ICB is e

As COVID-19 has been raging across the globe in the past year, it has not only constituted tremendous hazards to the safety and well-being of human beings but also incurred immeasurable economic losses. Although most of COVID-19 patients remain asymptomatic or experience only mild symptoms, about 20% suffer overt pneumonia and roughly 5% cases progress to life-threatening Acute Respiratory Distress Syndrome (ARDS) and severe or atypical systemic inflammation. Then how does COVID-19 differ from c